• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
Trevi Therapeutics Reports Q3 Earnings Improvement and Stock Surge
03:37
Nov14
Trevi Therapeutics released FY2025 9 Months Earnings on November 13 After-Market EST, with actual revenue of USD 0 and EPS of USD -0.2636
00:00
Trevi Therapeutics released FY2025 Q3 earnings on November 13 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0813 (forecast USD -0.0977)
00:00
Nov6
Trevi Therapeutics to Release FY2025 Q3 Earnings on November 13 After-Market (EST), Forecast EPS -0.0977 USD
00:07
Oct3
JonesTrading Reiterates Buy Rating for Trevi Therapeutics
13:06
Aug7
Trevi Therapeutics released FY2025 Q2 earnings on August 7 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.0943 (forecast USD -0.0988)
23:00

Schedules & Filings

Schedules
Filings
Nov13
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -11.8 M, EPS -0.0813

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -12.3 M, EPS -0.0943

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -10.34 M, EPS -0.0879

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More